SBRA vs WELL

Key Takeaways

• Scale Divide: WELL commands a market capitalization of approximately $147 billion, roughly 29 times larger than SBRA's $5.1 billion, creating fundamentally different risk and growth profiles.
• Dividend vs. Growth: SBRA offers a substantially higher dividend yield (around 6–6.5%) compared to WELL's approximately 1.4%, making SBRA more attractive for income-oriented investors, while WELL has delivered superior total returns driven by price appreciation.
• Momentum Divergence: WELL has significantly outperformed SBRA over the past year, with total returns exceeding 40% compared to SBRA's roughly 17–27%, driven by aggressive global acquisitions and stronger same-store operating metrics.
• Global vs. Domestic: WELL operates across the United States, Canada, and the United Kingdom, while SBRA remains focused exclusively on U.S. markets, giving WELL broader diversification and demographic tailwinds.
• Balance Sheet Quality: Both REITs maintain disciplined leverage, with WELL's Net Debt to Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) at 3.33x and SBRA's at 5.00x, positioning WELL with stronger credit metrics and recent S&P and Moody's upgrades.
• Sector Tailwinds: Both companies benefit from an aging population and rising demand for senior housing and healthcare real estate, but WELL's scale allows it to capture a larger share of these demographic trends.

Introduction

Investors evaluating healthcare real estate investment trusts (REITs) frequently encounter two names at opposite ends of the size spectrum: SBRA (Sabra Health Care REIT, Inc.) and WELL (Welltower Inc.). Both own and operate properties serving the healthcare industry — including skilled nursing facilities, senior housing communities, and outpatient medical centers — yet they differ dramatically in scale, strategy, and market positioning. This comparison is particularly relevant for investors deciding between a high-yield, smaller-cap REIT with a targeted U.S. footprint and a global industry titan with an aggressive growth trajectory. Understanding how these two stocks stack up across key dimensions can help clarify which better aligns with a given portfolio strategy in the current environment.

SBRA Overview and Recent Performance

SBRA, headquartered in Tustin, California, is a healthcare REIT that owns and invests in real estate serving the healthcare industry, with a portfolio spanning skilled nursing and transitional care facilities, senior housing communities (both leased and managed), behavioral health facilities, and specialty hospitals. As of recent filings, the company's investment portfolio includes roughly 425 properties spread across the United States. SBRA's business model relies on both triple-net lease structures — where tenants bear most operating costs — and managed senior housing operations, which provide more direct exposure to property-level performance.

In recent months, SBRA has been actively repositioning its portfolio toward managed senior housing, closing approximately $450 million in investments during 2025 at an estimated average initial cash yield of 7.5%. The company has also been divesting select skilled nursing facilities, completing the disposition of seven such properties in the fourth quarter of 2025. Same-store managed senior housing Cash NOI (Net Operating Income) grew by roughly 15% year-over-year on average during 2025, reflecting improving occupancy and margins. For 2026, SBRA has guided to Normalized FFO (Funds From Operations, a key REIT profitability metric) of $1.49 to $1.53 per share, representing mid-single-digit growth over the prior year. SBRA's stock has delivered a trailing twelve-month total return in the mid-to-high 20% range, reflecting a solid performance, though with more modest momentum than larger peers.

WELL Overview and Recent Performance

WELL, based in Toledo, Ohio and a constituent of the S&P 500, is the largest healthcare REIT globally, with a market capitalization approaching $147 billion. Welltower invests alongside leading seniors housing operators, post-acute care providers, and health systems, operating across three primary segments: Seniors Housing Operating (SHO), Triple-net properties, and Outpatient Medical facilities. Its portfolio is concentrated in major, high-growth markets in the United States, Canada, and the United Kingdom.

WELL has been executing at a remarkable pace in recent quarters. Total portfolio same-store NOI growth reached 12.9% in the first quarter of 2025, driven by an exceptional 21.7% from its Seniors Housing Operating portfolio, powered by occupancy gains and strong Revenue Per Occupied Room (RevPOR) growth. The company's acquisition activity has been transformative: it entered into a definitive agreement to acquire a $4.6 billion portfolio of ultra-luxury seniors housing communities operated by Amica Senior Lifestyles, and has also made major UK acquisitions including portfolios operated by Barchester (approximately £5.2 billion) and HC-One (approximately £1.2 billion). WELL's credit profile has strengthened substantially, with both S&P and Moody's upgrading the company to A- and A3 ratings respectively. The stock has delivered outstanding returns, gaining roughly 50% in 2025 and continuing its upward trajectory in 2026, with a five-year total return exceeding 237%.

Trending AI Robots

For investors seeking a data-driven edge in evaluating stocks like SBRA and WELL, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to navigate shifting market conditions. Tickeron hosts hundreds of AI trading bots that scan thousands of tickers across the market, but only the most effective and timely performers earn a spot in the Trending AI Robots section. These bots employ diverse trading styles and strategies — ranging from short-term momentum plays to longer-term trend-following approaches — each with its own performance statistics, win rates, and preferred ticker sets. The curated selection is updated to reflect current market dynamics, helping traders and investors identify which AI-driven strategies are resonating with real-time conditions without requiring manual analysis of hundreds of individual bots. Explore the Trending AI Robots page to see which automated strategies are currently positioned for success.

Head-to-Head Comparison

The contrast between SBRA and WELL is stark across nearly every dimension beyond their shared healthcare REIT classification. The most immediate difference is market capitalization: WELL at approximately $147 billion versus SBRA at approximately $5.1 billion. This scale gap translates into fundamentally different investment profiles. WELL's enormous balance sheet supports multi-billion-dollar portfolio acquisitions and international expansion, while SBRA's more targeted approach focuses on optimizing a concentrated U.S. portfolio through strategic acquisitions in the $50–$150 million range.

From a dividend perspective, SBRA is the clear income leader. With a quarterly dividend of $0.30 per share and an annualized yield exceeding 6%, SBRA appeals strongly to income-seeking investors. WELL's quarterly dividend of $0.74 per share translates to a yield of approximately 1.4% — relatively modest by REIT standards — reflecting the market's willingness to bid up WELL's stock price in anticipation of continued capital appreciation rather than current income.

On growth dynamics, WELL holds a commanding advantage. Its same-store NOI growth figures — particularly the 20%-plus expansion in its Seniors Housing Operating portfolio — significantly outpace SBRA's already-impressive mid-teens growth in managed senior housing. WELL's aggressive acquisition strategy, spanning North America and the UK, also opens avenues for growth that SBRA's domestic-focused model cannot replicate. However, SBRA's higher initial acquisition yields (7.0–8.2%) suggest the company is finding attractive risk-adjusted returns in a more targeted deal pipeline.

Risk profiles also diverge. WELL's credit ratings (A- from S&P, A3 from Moody's) and lower leverage (Net Debt to Adjusted EBITDA of 3.33x) provide a significant margin of safety. SBRA's leverage at 5.00x is reasonable for a REIT but less robust. SBRA's higher exposure to skilled nursing facilities — a segment with greater reliance on government reimbursement through Medicare and Medicaid — introduces policy risk that WELL, with its greater emphasis on private-pay senior housing, is partially insulated from.

Tickeron AI Verdict

Based on observable market data and trend analysis, Tickeron's AI-driven assessment framework would likely favor WELL in the current market environment. The rationale rests on several converging factors: WELL's superior and sustained price momentum, stronger same-store operating metrics across its Seniors Housing portfolio, a larger and more diversified acquisition pipeline spanning three countries, and a stronger balance sheet with recently upgraded credit ratings. While SBRA's high dividend yield and disciplined capital deployment strategy make it an appealing choice for income-focused investors, the combination of relative strength in price trends, earnings growth trajectory, and institutional-quality credit metrics tilts the probabilistic assessment in WELL's direction. That said, AI-driven models are inherently dynamic, and shifts in market conditions — such as a rotation toward yield-oriented strategies or changes in healthcare policy — could alter the relative attractiveness of each stock.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations